Thank you to the Cancer League of Colorado and MDC/Richmond Homes Foundation! At the end of 2025, they matched $2 for every $1 given to the CU Cancer Center Research Fund and surpassed their $600,000 goal. We appreciate all those who made gifts to cancer research and clinical trials! 💛

What is radon? How does it affect your lung cancer risk? Why does Colorado have a high amount of radon? Get these questions answered from experts at this Colorado Department of Public Health and Environment-sponsored event on 1/21 at 11:00 a.m. RSVP here: https://bit.ly/49qTaO7

For our local Colorado cancer researchers @cucancercenter.bsky.social @nucleosomepolice.bsky.social @cucancerbio.bsky.social

“Right patient. Right drug. Right time,” says CU Cancer Center leader Christopher Lieu, MD, about his patient Colin Kiesel's response to a new drug called Zenocutuzumab ⬇️ https://www.uchealth.org/today/zenocutuzumab-bizengri-offers-hope-young-pancreatic-cancer-patient/

For all the good that it does, chemotherapy is also often accompanied by side effects, including nausea, fatigue, and hair loss. CU Cancer Center's Erin Schenk, MD, PhD, shares advice on how to manage those side effects ⬇️ https://news.cuanschutz.edu/cancer-center/managing-chemotherapy-side-effects

Ed King, a head and neck cancer survivor and a member of the CU Cancer Center’s Community Advisory Council, holds monthly meetings where other survivors can share stories and access information from various medical experts from around the country ⬇️ https://bit.ly/4svPPEV

CU Cancer Center's Rebecca Schweppe, PhD, Bryan Haugen, MD, and Jennifer Richer, PhD, have received a DOD Cancer Idea Award to investigate the role of androgen receptors in thyroid cancers that develop resistance to BRAF inhibitors ⬇️ https://bit.ly/3YqOP7j

Connect to Care, a partnership between CU Cancer Center’s Office of Community Outreach & Engagement and Women’s Wellness Connection is working to detect cancer early and help women obtain treatment they might not be able to access otherwise ⬇️ https://bit.ly/49LxFrc

Don’t step back from science. Stacy Fischer, MD, encourages the next generation to stay committed, reminding them that their creativity and determination are the foundation of future cancer breakthroughs. Watch the full interview: youtu.be/wx-nbGDegRo?...

Join us on 2/5 for "Hope and Healing: Gynecologic Cancer Survivorship & Beyond" a gynecologic cancer educational conference designed to guide patients, survivors, and the community. Register now: https://bit.ly/4998sa4

Hitting the slopes more this new year? Even during winter, be sure to apply sunscreen! Learn more about staying safe in the winter sun ⬇️ https://news.cuanschutz.edu/cancer-center/winter-sun-skin

Have you tested your home for radon? 🏠 The CU Cancer Center's Office of Community Outreach and Engagement is offering free radon test kits ⬇️ https://news.cuanschutz.edu/cancer-center/free-radon-testing-kits

Don't put off your cancer screenings this year! Cancers detected early generally have the greatest chance of successful treatment or cure. Learn more here: https://bit.ly/3VwyAT6

Is your New Year's resolution to quit tobacco products? With the 2Morrow Health app, Colorado residents over the age of 13 get 12 months of free acceptance and commitment therapy. Learn more about the program and sign up here: https://bit.ly/40CQ3ws

Four in 10 cancer cases are preventable! Make cancer prevention a goal for the new year. Here are 10 ways you can prevent cancer in 2026 ⬇️ https://news.cuanschutz.edu/cancer-center/schulick-fischer-studts-top-10-prevention

With funding from a NIH grant, CU Cancer Center's Dan Regan, DVM, and Breelyn Wilky, MD, are studying a fibroblast-targeting drug, in conjunction with standard-of-care chemotherapy, in dogs with naturally occurring osteosarcoma ⬇️ https://bit.ly/48RmRrf

@oncodaily.bsky.social has named Enrique Soto Pérez de Celis, MD, PhD, CU Cancer Center's associate director for global oncology, as one of the 100 Most Influential People in Oncology in 2025! 👏 ⬇️ https://oncodaily.com/community/enrique-soto-427482

✨ Best of the CU Cancer Center newsroom in 2025 ✨ @drcamidge.bsky.social has spent his career fighting lung cancer. In 2022, that fight turned personal when he received a diagnosis of his own. Read this story: https://bit.ly/3MMXsGI See the other top stories: bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ Virginia Borges, MD, director of the Young Women’s Breast Cancer Translational Program at the CU Cancer Center, explores contributing factors. Read this story: https://bit.ly/3MMXsGI See the other top stories: bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ New research from @jdegregori.bsky.social, PhD, suggests that COVID-19 may awaken dormant cancer cells, potentially increasing recurrence risk in certain patients. Read this story: https://bit.ly/48CQlI3 See the other top stories: bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ The FDA advises those with a family history of medullary thyroid cancer to avoid GLP-1 drugs. Bryan Haugen, MD, breaks down the science. Read this story: https://bit.ly/44ECOyx See the other top stories: https://bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ Learn what younger women need to know about fertility and pregnancy when they are diagnosed with breast cancer. Read this story: https://bit.ly/4jehaar See the other top stories: https://bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ Richard Wood, MD, Rachel Kruse, MD, and Eden Bernstein, MD, share strategies for counseling patients on reducing alcohol-related cancer risk. Read this story: https://bit.ly/3WzJwSv See the other top stories: https://bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ Catherine Danis, PhD, and M. Eric Kohler, MD, PhD, developed ALA-CART, aimed to improve outcomes for lymphocytic cancer patients. Read this story: https://bit.ly/4qn9zc3 See the other top stories: https://bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ Matthew Sikora, PhD, explains why lobular breast cancer can be harder to diagnose and how new research is paving the way for better treatments. Read this story: https://bit.ly/47B9b2S See the other top stories: https://bit.ly/4j3ONLW

During the holidays, it can be difficult to talk about cancer with a loved one who was newly diagnosed. CU Cancer Center's Kyle Concannon, MD, offers advice: https://bit.ly/3XPpALp

✨ Best of the CU Cancer Center newsroom in 2025 ✨ When Denver Broncos' Alex Singleton faced a testicular cancer diagnosis, his journey underscored the importance of early detection and patient-centered care. Read this story: https://bit.ly/3MBsHV6 See the other top stories: https://bit.ly/4j3ONLW

✨ Best of the CU Cancer Center newsroom in 2025 ✨ Swati Patel, MD, breaks down why prep matters, so you can take this important step in preventing colorectal cancer with confidence. Read this story: https://bit.ly/3R3oR5V See the other top stories: https://bit.ly/4j3ONLW

CU Cancer Center researcher Zachary Clayton, PhD, is investigating whether high-intensity interval training prior to chemotherapy can prevent premature vascular aging for breast cancer patients ⬇️ https://bit.ly/4rXrjw2

Congrats to CU Cancer Center members @drcamidge.bsky.social, MD, PhD, Russell Glasgow (@russgl.bsky.social), PhD, and Angelo D’Alessandro (@dalessandrolab.bsky.social), PhD, for being named on the Clarivate Highly Cited Researchers 2025 list! 👏

CU Cancer Center member Jonathan Samet, MD, MS, shares his reflection on the 80th anniversary of the atomic bombings of Hiroshima and Nagasaki, Japan, and the research the Radiation Effects Research Foundation has been doing with survivors ⬇️ https://bit.ly/4rVKnuC

Happy Holidays! For four decades, we’ve worked toward one goal, prevent and conquer cancer. In 2026, we keep moving forward—together.

Molishree Joshi, PhD, and Kimberly Jordan, PhD, leaders of two CU Cancer Center shared resources, have received the first-ever National Cancer Institute R50s for core-based scientists at CU Anschutz (@cuanschutz.bsky.social)! 👏 Learn more: https://bit.ly/4s2TXMd

Congrats to Tim Milosich and Kelly McIlvride, MAcc, CMA, on their new roles! Milosich has been promoted to clinical trials finance program director, and McIlvride has been promoted to Cancer Center finance program director. 👏

Yesterday afternoon, CU Cancer Center staff gathered to celebrate the accomplishments made in 2025 while enjoying cookies, showing off of holiday sweaters, and of course, good company! 🎉 ❄️

With a Tumor Host Interactions Program grant along with the mentorship of two CU Cancer Center investigators, Migachelle Romano is researching how obesity-driven inflammation is promoting pancreatic cancer progression ⬇️ https://bit.ly/4j1ITuW

#ASH25: Did you know that clonal hematopoiesis affects at least 20% of adults over 60? Cancer Center's @ericpietras.bsky.social#ASH25 PhD, shares his insights on the role of this condition in cancer and aging at the 2025 American Society of Hematology Presidential Symposium ⬇️ https://bit.ly/3KOKdoi

Congratulations to Matt Lee! Lee stepped into his new position as program director of clinical research operations at the Cancer Clinical Trials Office after multiple roles since 2014.

Leadership, to Dan Gustafson, PhD, means trust, teamwork, and growth — values shared through our partnership with the Flint Animal Cancer Center. Watch the full interview: youtu.be/ZFSzFb55KDs

CU Cancer Center member Ajay Major (@majorajay.bsky.social), MD, MBA, led a study of more than 25,000 long-term childhood cancer survivors, to learn more about their rates of colorectal cancer and what their doctors can do about it ⬇️ https://bit.ly/3MkDl2t

Breast cancer is the leading cause of cancer death among Hispanic women in the U.S. Haidee Hernandez's story shows why early diagnosis and treatment matter: https://bit.ly/4iX8RzB

#Glioblastoma is trending after former NBA player Jason Collins shared his stage 4 diagnosis, and "Confessions of a Shopaholic” author Sophie Kinsella passed away after a two-year battle. Douglas Ney, MD shares what glioblastoma is, and why younger people are being diagnosed. https://bit.ly/497RCIy

From the fall 2025 issue of the C3: When CU Buffaloes football coach Deion Sanders was diagnosed with bladder cancer, his treatment team included CU Cancer Center member Janet Kukreja, MD, an expert in robotic bladder removal surgery ⬇️ https://bit.ly/4pUnSV5

Congrats to CU Cancer Center's Debashis Ghosh, PhD, for receiving the Outstanding Impact Award and Lectureship from the Western North American Region of the International Biometric Society! ⬇️ https://bit.ly/3XI8oaQ

Looking forward to the CU Cancer Center’s next 40 years and beyond, we asked several of our top minds: What is one big unanswered question about cancer? 🤔 ⬇️ https://news.cuanschutz.edu/cancer-center/cancer-unanswered-questions

From the fall 2025 issue of the C3: Fahiima Abdullahi plans to apply to medical school in the spring after graduating from the PIKE-PREP research training program for post-baccalaureate students and the Cancer Research Training and Education Coordination program ⬇️ https://bit.ly/44LJLxG

Seeing patients live longer, fuller lives because of scientific progress is what keeps Stacy Fischer, MD, committed to her field. Every breakthrough strengthens her resolve to support patients — and inspire future scientists. Watch the full interview: youtu.be/wx-nbGDegRo

.@amergastroassn.bsky.social's new clinical practice guideline on the surveillance of Barrett’s esophagus provides eight evidence-based recommendations to optimize cancer prevention through risk-based, personalized care. See the new guideline led by Sachin Wani, MD: https://bit.ly/4ayv04Z

From the fall 2025 issue of the C3: Research led by CU Cancer Center Deputy Director James DeGregori, PhD, finds that respiratory viral infections such as COVID trigger inflammation that can awaken dormant cancer cells in the lungs ⬇️ https://bit.ly/48CQlI3

New research findings from CU Cancer Center members Bradley Corr, MD, and Benjamin Bitler, PhD, show a promising strategy for ovarian cancer patients who do not respond to existing treatments: https://bit.ly/3Kp2sAv